These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 17216192)

  • 1. A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation.
    Boccardi C; Cecchettini A; Caselli A; Camici G; Evangelista M; Mercatanti A; Rainaldi G; Citti L
    Cell Tissue Res; 2007 Apr; 328(1):185-95. PubMed ID: 17216192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells.
    Boccardi C; Cecchettini A; Caselli A; Camici G; Evangelista M; Mercatanti A; Rainaldi G; Citti L
    Cell Tissue Res; 2007 Jul; 329(1):119-28. PubMed ID: 17406898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: a proteomic analysis.
    Qi YX; Qu MJ; Long DK; Liu B; Yao QP; Chien S; Jiang ZL
    Cardiovasc Res; 2008 Oct; 80(1):114-22. PubMed ID: 18540023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics changes in adhesion molecules: a driving force for vascular smooth muscle cell phenotypic switch.
    Rocchiccioli S; Ucciferri N; Comelli L; Trivella MG; Citti L; Cecchettini A
    Mol Biosyst; 2012 Apr; 8(4):1052-9. PubMed ID: 22215216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1.
    Kusch A; Tkachuk S; Tkachuk N; Patecki M; Park JK; Dietz R; Haller H; Dumler I
    Cardiovasc Res; 2009 Jul; 83(1):115-22. PubMed ID: 19380416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain.
    Padró T; Peña E; García-Arguinzonis M; Llorente-Cortes V; Badimon L
    Cardiovasc Res; 2008 Jan; 77(1):211-20. PubMed ID: 18006454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle.
    Lee CK; Park HJ; So HH; Kim HJ; Lee KS; Choi WS; Lee HM; Won KJ; Yoon TJ; Park TK; Kim B
    Proteomics; 2006 Dec; 6(24):6455-75. PubMed ID: 17099934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
    Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
    Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells.
    Molero L; García-Méndez A; Alonso-Orgaz S; Carrasco C; Macaya C; López Farré AJ
    Clin Sci (Lond); 2005 Nov; 109(5):457-63. PubMed ID: 16033335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
    Liu Y; Dolence J; Ren J; Rao M; Sreejayan N
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
    Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
    Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells.
    Wassmann S; Wassmann K; Jung A; Velten M; Knuefermann P; Petoumenos V; Becher U; Werner C; Mueller C; Nickenig G
    J Mol Cell Cardiol; 2007 Sep; 43(3):301-7. PubMed ID: 17659301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
    Kiyan J; Haller H; Dumler I
    Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
    Rudijanto A
    Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D; Shi X; Jiang BH; Fang J
    Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth.
    Patecki M; von Schaewen M; Tkachuk S; Jerke U; Dietz R; Dumler I; Kusch A
    Biochem Biophys Res Commun; 2007 Aug; 359(3):679-84. PubMed ID: 17548050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
    Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells.
    Liu DH; Yuan HY; Cao CY; Gao ZP; Zhu BY; Huang HL; Liao DF
    Acta Pharmacol Sin; 2007 Dec; 28(12):1907-13. PubMed ID: 18031603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.